Advisory Committee to the Director, Centers for Disease Control and Prevention, 43694 [05-15019]
Download as PDF
<![CDATA[
43694
Federal Register / Vol. 70, No. 144 / Thursday, July 28, 2005 / Notices
assistance to patients, doctors, and the
general public.
The ICA has over 20 years of
achievement unmatched by any other
health organization dealing with IC
issues. Some of these achievements
include:
• Public awareness—the ICA has
consistently attracted media attention to
IC. Numerous articles featuring IC and
the ICA have been published from the
‘‘New York Times,’’ ‘‘SELF Magazine,’’
‘‘Good Housekeeping,’’ and many other
national magazines. Subject-matter
experts from the ICA have appeared on
national TV and radio programs to
include ABC’s ‘‘Good Morning
America,’’ CNN, and National Public
Radio.
• Physician and Patient Education—
Subject-matter experts from the ICA
have published numerous articles on IC
for professional journals including
‘‘Urology’’ and the ‘‘World Journal of
Urology.’’ The ICA has worked closely
with the NIDDK Division of Urology for
over 15 years and has co-sponsored with
the NIDDK, international scientific
conferences as well as national IC
patient meetings on IC biannually. ICA
has also sponsored numerous regional
educational programs for patients
throughout the United States each year.
• Patient Support—The ICA provides
a toll-free 800 number designed to
quickly assist both IC patients and
healthcare providers. ICA also provides
nationwide individual support via
telephone and e-mail by ICA National
Patient Support Advocates; the
International IC Question Corner on its
Web site, where patients can e-mail the
ICA and receive one-on-one assistance
with their questions; the ICA Physician
Registry which helps IC patients find ICknowledgeable physicians; and IC
connections, which brings together
patients based on specific interests,
concerns and regions, and an
informational program on how to start
new IC support groups.
• Innovative resources—the ICA
published, and continues to regularly
update, a series of brochures and fact
sheets as well as ‘‘IC Treatment
Guidelines’’—the first comprehensive
summary of IC treatments and
medications designed for patients and
their physicians for use as the basis for
an individualized treatment plan. The
ICA also publishes an on-line monthly
´
news digest, ‘‘Cafe ICA,’’ and two
quarterly newsletters—the ‘‘ICA
Update,’’ the only printed newsletter on
IC in the United States, and the ‘‘ICA
Physician Perspectives.’’ ICA also
publishes a ‘‘Pocket Guide’’ series for
continuing patient education.
VerDate jul<14>2003
13:40 Jul 27, 2005
Jkt 205001
• Comprehensive Web Site—The
ICA’s Web site https://www.icahelp.org,
established in 1995, is the most
comprehensive Web site on IC available
today, receiving over 1.4 million hits
per month. The site includes: a Clinical
trials section, their on-line monthly
´
news digest—‘‘Cafe ICA,’’ IC Question
Corner which provides one-on-one
patient support, Treatment Options, a
section for health care providers, a
comprehensive research section, and
much more * * *.
• Non-profit leadership—the ICA
remains the only United States 501
(c)(3) registered non-profit organization
to fund IC research and provide
educational programs on IC for both
physicians and patients, as well as the
public at large.
This mission and ICA’s extensive
network of resources and record of
unmatched achievements over the last
20 years, makes it highly probable that
ICA will successfully implement and
complete all the required activities for
this program announcement. For these
reasons, the ICA is the only organization
being considered for this program
announcement.
C. Funding
Approximately $ 510,000 is available
in FY 2005 to fund this award. It is
expected that the award will begin on or
before September 1, 2005, and will be
made for a 12-month budget period
within a project period of up to five
years. Funding estimates may change.
D. Where To Obtain Additional
Information
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director,
Centers for Disease Control and
Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following Advisory
Committee meeting.
Name: Advisory Committee to the Director,
CDC.
Time and Date: 8:30 a.m.–4:30 p.m.,
August 25, 2005.
Place: Emory Conference Center, 1615
Clifton Road, Atlanta, Georgia 30329.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 75 people.
Purpose: The committee will provide
advice to the CDC Director on strategic and
other broad issues facing CDC.
Matters to Be Discussed: Agenda items will
include updates on CDC priorities with
discussions of program activities including
updates on CDC scientific and programmatic
activities, strategic imperatives, goals,
research agenda, and health equity.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robert Delaney, Executive Secretary,
Advisory Committee to the Director, CDC,
1600 Clifton Road, NE, M/S D–14, Atlanta,
Georgia 30333. Telephone (404) 639–7000.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
For general comments or questions
about this announcement, contact:
Technical Information Management,
CDC Procurement and Grants Office,
2920 Brandywine Road, Atlanta, GA
30341–4146; telephone: 770–488–2700.
For technical questions about this
program, contact: Richard S. Roman,
Project Officer, HCAS/DACH/
NCCDPHP/CDC, 4770 Buford Hwy.,
N.E., MS K–51, Chamblee, GA 30341;
telephone: 770–488–5144; e-mail:
rsr1@cdc.gov.
Dated: July 25, 2005.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 05–15019 Filed 7–27–05; 8:45 am]
Dated: July 22, 2005.
William P. Nichols,
Director, Procurement and Grants Office,
Centers for Disease Control and Prevention.
[FR Doc. 05–14927 Filed 7–27–05; 8:45 am]
Proposed Vaccine Information
Materials for Hepatitis A and Influenza
Vaccines; Interim Vaccine Information
Materials for Influenza Vaccines
BILLING CODE 4163–18–P
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
E:\FR\FM\28JYN1.SGM
28JYN1
]]>Agencies
[Federal Register Volume 70, Number 144 (Thursday, July 28, 2005)]
[Notices]
[Page 43694]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15019]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director, Centers for Disease Control
and Prevention
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Advisory Committee meeting.
Name: Advisory Committee to the Director, CDC.
Time and Date: 8:30 a.m.-4:30 p.m., August 25, 2005.
Place: Emory Conference Center, 1615 Clifton Road, Atlanta,
Georgia 30329.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 75 people.
Purpose: The committee will provide advice to the CDC Director
on strategic and other broad issues facing CDC.
Matters to Be Discussed: Agenda items will include updates on
CDC priorities with discussions of program activities including
updates on CDC scientific and programmatic activities, strategic
imperatives, goals, research agenda, and health equity.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Robert Delaney, Executive
Secretary, Advisory Committee to the Director, CDC, 1600 Clifton
Road, NE, M/S D-14, Atlanta, Georgia 30333. Telephone (404) 639-
7000.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: July 25, 2005.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 05-15019 Filed 7-27-05; 8:45 am]
BILLING CODE 4163-18-P
